Dare Bioscience BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

CSL Behring BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

Crucell BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

Aphios Corporation BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

Alexion Pharmaceuticals, Inc BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

Celgene Corporation BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

Cephalon, Inc BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

Danaher Corporation BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

NCT07707674 clinical trial report covering XNW-28012, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07714798 clinical trial report covering Universal STAR-T Cell(BriSTAR Immunotech), Phase 1, endpoints, sponsor, geography, readout timing and developmen

NCT07717086 clinical trial report covering HYR-PB21, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07719088 clinical trial report covering Psilocybin, Phase 1, endpoints, sponsor, geography, readout timing and development white space.